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Abstract 
The scavenging effect of Chinonin on NO and oxygen free radicals and its protective ffect on myocardium from the ischemia-reperfu- 
sion injury was studied with electron spin resonance (ESR) and chemiluminescence techniques. Chinonin can effectively inhibit the 
oxidative activity of ONOO-, (the IC50 = 7 × 10 -5 mmol/L) and scavenge oxygen free radicals generated from the reaction of xanthine 
and xanthine oxidase (the IC5o = 2.5 × 10 -4 mmol/l). It is difficult to find another antioxidant which can scavenge so effectively both 
ONOO- and oxygen free radicals imultaneously. In the system of ischemia-reperfusion injury of myocardium, Chinonin can, in parallel, 
scavenge the NO and oxygen free radicals generated from the ischemia-reperfused myocardium, and decrease the activities of lactate 
dehydrogenase (LDH) and creatine kinase (CK) in the coronary artery effluent of ischemia-reperfused h art and therefore protect the heart 
from ischemia-reperfusion injury. The protective ffect of 0.1 mmol/1 Chinonin is similar to that of 1500 U/ml SOD and catalase. 
Kevwords: Chinonin; Nitrous oxide; lschemia-reperfusion njury; Oxygen free radical; Electron spin resonance 
I. Introduction 
The incidence and mortality of heart disease are the 
highest among all diseases in China and all over the world, 
and they are increasing with time and rising living stan- 
dards. It is important o study the mechanisms that cause 
this disease and find effective medicines to prevent and 
cure it. More and more evidence indicates that oxygen free 
radicals play an important role in the generation and 
development of heart disease. The role of antioxidants in 
preventing and curing the heart disease has attracted the 
attention of increasingly more biological and medical 
workers. Myocardial ischemia-reperfusion njury is a model 
Abbreviations: CAT, catalase; CK, creatine kinase; CN, Chinonin; 
ESR, electron spin resonance; Hb, hemoglobin; IR, ischemia reperfusion; 
LA, L-arginine; LDH, lactate dehydrogenase; NAME, NG-nitro-L-arginine 
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oxidase. 
* Corresponding author. Fax: + 86 202 7837. 
0925-4-439/96/$15.00 © 1996 Elsevier Science B.V. All rights reserved 
SSDI 0925-4439(95)00112-3 
widely used for studying the mechanisms of heart disease, 
which shows a relationship between oxygen free radical 
paradox and physiological function with myocardial is- 
chemia-reperfusion i jury [1-4]. But the studies on the 
role of NO free radicals in the ischemia-reperfusion injury, 
especially by ESR technique, are not so popular. The 
studies on the role of antioxidants in scavenging NO free 
radicals and protecting the heart from ischemia-reperfusion 
injury are very difficult to be found in the literature. NO 
has many physiological functions, such as endothelium-de- 
rived relaxing factor (EDRF), inhibiting coagulation of 
platelet and reverse messenger for neuron transmission 
[5-7]. But it is also a free radical and plays 'double edges' 
in the body; e.g., in addition to its biological functions, it 
can also react with the components of cells and be poi- 
sonous to the cells. Many of the cellular actions of NO can 
be attributed to the tendency of this radical molecule to 
bind to and thus modify the activities of iron-nitrosyl 
complexes, for example, aconitase and mitochondrial elec- 
tron transfer, as well as ribonucleotide reductase, can be 
destroyed [8,9]. NO binds to hemoglobin (Hb) 1000 times 
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stronger than CO [10]. Because of the characteristic para- 
magnetic properties of iron-nitrosyl complex and its ability 
to detect such complexes against a large background of 
diamagnetic species in whole cells and tissues, ESR spec- 
troscopy has been utilized extensively in these studies. 
This is a sensitive and specific technique to detect NO. 
Using this method we got the ESR signal of NO bound to 
Hb in the blood from the ischemia-reperfused kidney [11]. 
This technique was used in this work to study the genera- 
tion of NO, its synergic effect with oxygen free radicals in 
the myocardium of ischemia-reperfusion injury, and the 
protective ffect of Chinonin on the myocardium from the 
ischemia-reperfusion injury. The scavenging effect of Chi- 
nonin on oxygen free radicals generated from 
xanthine/xanthine oxidase and its inhibitory effect on the 
oxidative activity of ONOO- was also studied. 
2. Materials and methods 
Agents: L-arginine, NC-nitro-L-arginine methyl ester 
(NAME), luminol, xanthine, xanthine oxidase, SOD (su- 
peroxide dismutase) and catalase were purchased from 
Sigma Chemicals. The reagents for measurement of the 
activities of lactase dehydrogenase (LDH) and creatine 
kinase (CK) were purchased from AusBio Co. Chinonin 
was provided by 999 Enterprise Group, Medical and Phar- 
maceutical Research Institute. Other chemical agents pur- 
chased in China are of analytical level. 
NO preparation: 20 g copper scraps were added into 
100 ml nitric acid (50%) in a round-bottomed flask and the 
generated gas was led to a cone flask with distilled water, 
then led to another cone flask with 2 mol/1 KOH solution. 
The washed gas was used directly in the experiment [12]. 
Preparation of ONO0-:  ONOO- was synthesized by 
a quenching flow reactor [13]. 0.6 mol/1 NaNO 2 and 0.6 
mol/1 HC1/0.7 mol/1 H20 2 were pumped into the two 
upper holes of a T-shaped tube at 26 ml/min and mixed, 
thus ONOO- was generated in the part of the tube with 3 
mm diameter. 1.5 mol/1 NaOH was pumped into the 
central hole of the T-tube at the same speed to meet the 
generated ONOO-, transferring it to alkaline solution. The 
solution passed a MnO 2 column (1 × 5 cm) to remove 
excessive H20 2, then frozen at -20°C. The yellow layer 
of the frozen sample is the salt of ONOO-. It was used as 
ONOO- and its concentration was measured with the 
absorbance at 302 nm (E = 1670 mM-lcm - i) [14]. 
Scavenging effects of Chinonin on oxygen free radicals 
generated from the reaction system of xanthine (0.16 mmol 
/ l ) ,  xanthine oxidase (0.095 U/ml) :  The oxygen free 
radicals generated from this system were measured by 
luminol-dependent chemiluminescence. The scavenging ef- 
fects were calculated from the decrease of the chemilumi- 
nescence after addition of Chinonin to the system. 
Inhibitory effects of Chinonin on the oxidative activity 
of ONO0 -: The oxidative activity of ONOO- was mea- 
sured by luminol-dependent chemiluminescence and the 
inhibitory effects were calculated from the decrease of 
chemiluminescence after addition of Chinonin to the sys- 
tem. 
Measurement of NO bound to Hb: The solution of Hb 
(1 mmol/1) was deoxygenated by repeat evaluation and 
flushing with nitrogen gas. The NO prepared from above 
system was added to the solution and the solution was 
frozen in liquid nitrogen. The temperature in the cavity of 
the ESR spectrometer was adjusted to 123K and the 
sample frozen in liquid nitrogen was transferred into the 
cavity. After the temperature was equilibrated, the ESR 
spectrum was recorded. 
Ischemia and reperfusion of the heart: Male SD rats 
(250-300 g) were obtained from Institute of Zoology, 
Academia Sinica. The animals were divided randomly into 
12 groups. The rats were anaesthetized with 3% pento- 
barbital (10 ml/kg). After heparinization (5000 U/kg), 
the hearts were excised and put immediately into standard 
physiological solution (4°C). The hearts were cannulated 
through artery and perfused with oxygenated Krebs-bi- 
carbonate (KB) buffer (NaC1 124 mmol/1, KC1 4.7 
mmol/1, MgC12 1.2 mmol/l, NaHCO 3 19.5 retool/l, 
KH2PO 4 1.2 mmol/1, CaC1 z 2.5 mmol/1, 0.5 mmol/l  
EDTA-Na, glucose 10 mmol/1) at 37°C under pressure of 
80 mmHg (95% 0 2 , 5% CO 2, pH 7.4) according to a 
modified Langendorff method [15] for 10 min and the 
rhythmically beating hearts were taken as normal heart. 
Then the hearts were subjected to ischemia for 120 min, 
which were then taken as the ischemic hearts. The is- 
chemic hearts reperfused for 10 min with oxygenated KB 
buffer were taken as the group of ischemia-reperfused 
hearts; the hearts reperfused with oxygenated KB buffer 
containing L-arginine were taken as the group of 
ischemia-reperfusion hearts with L-arginine; the hearts 
reperfused with oxygenated KB buffer with 100 mmol/l  
NAME were taken as the group of ischemia-reperfusion 
heart with NAME; the hearts reperfused with oxygenated 
KB buffer containing (500 U/ml)  SOD/catalase were 
taken as the group of ischemia-reperfusion heart with 
SOD/catalase; the hearts reperfused with oxygenated KB 
buffer containing 100 /zmol/1 Fe 2÷ were taken as the 
group of ischemia-reperfusion heart with Fe2+; the hearts 
reperfused with oxygenated KB buffer containing 100 
/xmol/l H20 2 were taken as the group of ischemia-reper- 
fusion heart with H202; the hearts reperfused with oxy- 
genated KB buffer containing 100 /xmol/1 Fe2+/H202 
(100 /xmol/l Fe z+ and H202 in the buffer were pumped 
into a cell which cannulated to the artery through a three- 
pathway set) were taken as the group of ischemia-reperfu- 
sion heart with Fe2+/H202; the hearts reperfused with 
oxygenated KB buffer containing xanthine (0.32 
mmoi/1)/xanthine oxidase (0.093 U/ml)  (0.32 mmol/L 
xanthine and 0.093 U/ml  xanthine oxidase in the buffer 
were pumped into a cell which cannulated to the artery 
through a three-pathway set) were taken as the group of 
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ischemia-reperfusion heart with xanthine/xanthine oxi- 
dase; the hearts reperfused with oxygenated KB buffer 
containing 100 /zmol/ l  Chinonin were taken as the group 
of the ischemia-reperfusion heart with Chinonin; the hearts 
reperfused with oxygenated KB buffer containing 100 
mmol/1 L-arginine and 100 /zmol/1 Chinonin were taken 
as the group of the ischemia-reperfusion heart with L- 
arginine and Chinonin. The coronary artery effluent were 
collected during the reperfusion for the analysis of LDH 
and CK activities. After reperfusion, the myocardium was 
cut into small cylinders of 2.5 mm diameter with cold 
scissors which were previously in liquid nitrogen and put 
immediately into a quartz tube of 3 mm diameter, packed 3 
cm in height, and then placed in liquid nitrogen. 
ESR measurement conditions: Above ESR spectra were 
recorded with a Varian El09 ESR spectrometer. X-band, 
100 kHz modulation with amplitude 8G, microwave power 
I roW, time constant 0.128 s, central magnetic field 3250G, 
sweep width 500G, temperature 123K. 
Measurement of Chinonin free radicals: l0 mmol/1 
Chinonin was mixed with 100 /~mol/H2OE/Fe 2+ and 
immediately added with 0.1 mmol NaOH solution. Then 
the sample was sucked into a quartz capillary and mea- 
sured for ESR spectrum. The ESR conditions were: Mi- 
crowave power 0.1 mW, modulation amplitude 0.02G, 
swept width 5G with speed of 0.3 G/min. 
Measurement of LDH and CK activities: LDH and CK 
activities in the coronary artery effluent were measured by 
means of the enzyme dynamic method using HITACHI 
7150 Automatic Analyzer with AUsBio CO. standard 
reagents. 
Data analysis: Comparison between the treatment 
groups was made by analysis of Newman-Keuls test. A 
difference was considered statistically significant when 
P < 0.05. 
3. Resu l ts  
3.1. Scavenging effects of Chinonin on oxygen free radi- 
cals 
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Fig. 1. Scavenging effect of Chinonin on oxygen free radicals generated 
from xanthine/xanthine oxidase system. (The error bars are standard 
deviations.) 
hibitory effect of Chinonin on the oxidative activity of 
ONOO-. It can be seen that Chinonin has a very strong 
inhibitory effect on the oxidative activity of ONOO-. The 
IC50 is about 7 × 10 -5 mmol/ l .  
3.3. Scavenging effect of Chinonin on NO free radicals 
generated from ischemia-reperfusion myocardium 
Fig. 4 shows the different ESR spectra of NO bound to 
hemoglobin (Hb) recorded at 123K. The ESR spectrum in 
Fig. 4a comes mainly from the NO bound to the a-subunit 
of Hb (90%a/10%fl) ,  the ESR spectrum in Fig. 4b partly 
comes from the NO bound to the c~-subunit of Hb and 
partly to /3-subunit of Hb (30%c~/70%B), and the ESR 
spectrum in Fig. 4c mainly comes from the NO bound to 
the /3-subunit of Hb (10%a/90%/3). The peaks at g = 
2.078 and g = 2.01 with three hyperfine splittings are 
predominantly from a-NO complex and the peaks at g = 
2.04 and g = 2.015 are attributable to /3-NO complex and 
nonheme iron-dinitrosy complex [16-20]. 
Fig. 5 shows the ESR spectra recorded at 123K from 
the myocardium of normal (Fig. 5a), ischemia (for 120 
min)-reperfusion (for 10 min) (Fig. 5b), ischemia (for 120 
min)-reperfusion (for 10 min) with 100 mmol/1 L-arginine 
(Fig. 5c) and ischemia (120 min)-reperfusion (10 min) 
The scavenging effects of Chinonin on oxygen free 
radicals generated from the reaction of xanthine/xanthine 
oxidase are shown in Fig. 1. It can be seen that Chinonin 
has strong scavenging effects on oxygen free radicals. The 
IC50 is about 2.5 X 10 -4 mmol/1. 
3.2. Inhibitory effects of Chinonin on the oxidative activity 
of ONO0 - 
ONOO- can oxidize luminol to give a very strong 
chemiluminescence which is dose-dependent on the con- 
centration of ONOO- (Fig. 2). This characteristic can be 
used to determine the inhibitory effect of an antioxidant on 
the oxidative activity of ONOO-. Fig. 3 shows the in- 
oo CO0 
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Fig. 2. The relation of luminol-dependent chemiluminescence with the 
concentration f ONOO-. (The error bars are standard deviations.) 
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Fig, 3. Inhibitory effect of Chinonin on the oxidative activity of ONOO-. 
(The error bars are standard deviations.) 
with 100 mmol/1 NAME (Fig. 5d). Only two peaks can be 
found at g = 2.0050 and g = 1.9372 respectively, which 
correspond to the semiquinone free radicals and transition 
metal cation on the spectrum of normal myocardium. Even 
after addition of L-arginine, there is no change in the 
spectra (Table i). In addition to these two peaks, there are 
other two peaks at g = 2.04 and 2.03 on the spectrum of 
the ischemia-reperfused myocardium. The peak at g = 2.04 
is similar to that of the /3-NO complex and g = 2.03 has 
tentatively been reported to attribute to oxygen or alkyl 
peroxide radicals [1-4]. When NAME, the inhibitor of NO 
synthetase, was added in the reperfusion solution, the 
signal at g = 2.04 decreased and after addition of L-arginine 
into the reperfusion solution, the signal at g = 2.04 in- 
creased in a dose-dependent way (Table 1), indicating that 
the signal at g = 2.04 connects with NO. After addition of 
SOD/catalase,  the signals at g = 2.04 and g = 2.03 de- 
creased simultaneously, and after addition of Fe2+/HzO2 
(or Fe 2+ and H20 2 alone) or xanthine/xanthine oxidase 
into the reperfusion solution, the peaks at g = 2.03 and 
g = 2.04 increased simultaneously (Table 1), indicating 
that the signals at g = 2.03 and g = 2.04 connect with 
oxygen free radicals. 
Fig. 5e shows the ESR spectrum from the myocardium 
of ischemia (for 120 min)-reperfusion (for 10 min) with 
100 /xmol/1 Chinonin. It can be seen that it is similar to 
that from the ischemia-reperfusion myocardium with 
NAME and SOD/catalase,  the peaks at g = 2.04 and 
g = 2.03 decreased significantly (data in Table 1). 
3.4. Protection effect of  Chinonin on myocardium from 
ischemia-reperfusion injury. 
Table 1 shows the activities of LDH and CK in the 
coronary artery effluent under different conditions. It can 
be seen that there is little LDH and CK activity in the 
coronary artery effluent from the normal heart, even with 
addition of L-arginine (1-100 mmol/1), indicating that 
L-arginine is not cytotoxic for normal heart. The activities 
of LDH and CK in the coronary artery effluent from 
ischemia-reperfused heart are higher than those from nor- 
mal heart, indicating that there is an ischemia-reperfusion 
injury. If a higher concentration of L-arginine was added 
g=2.0780 
DPPH 
g=2.0400 
H 
4 
g=2.0100 
Fig. 4. The ESR spectra of NO bound to different subunits of hemoglobin. (a) The ESR spectrum ainly comes from the NO bound to the a-subunit of Hb 
(90%or/10%]3 ); (b) the ESR spectrum partly comes from the NO bound to the a-subunit of Hb and partly to /3-subunit ofHb (30%a/70%]3) and (c) the 
ESR spectrum ainly comes from the NO bound to the ]3-subunit of Hb (10%ot/90%/3). The details of ESR conditions were described in Section 2. 
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Fig. 5. ESR spectra measured from the myocardium of control (a), ischemia-reperfusion (b), ischemia-reperfusion with 100 mmol / l  h-arginine (c), 
ischemia-reperfusion with 100 mmol /1  NAME (d), ischemia-reperfusion with 100 / ,mo l / l  Chinonin (e). The details of ESR conditions were described in 
Section 2. 
into the reperfusion buffer, the activities of LDH and CK 
increased significantly, indicating that the higher the con- 
centration of h-arginine included in the reperfusion solu- 
tion, the more serious ischemia-reperfusion injury occurred 
in the myocardium. Addition of SOD/catalase or NAME 
into the reperfusion buffer decreased the activities of LDH 
and CK in the coronary artery effluent from the ischemia- 
reperfusion heart, indicating that SOD/catalase and NAME 
protect the heart from ischemia-reperfusion i jury. Addi- 
tion of Fe2+/H202 (or Fe 2+ and H202 alone) or xan- 
thine/xanthine oxidase into the reperfusion buffer in- 
creased the activities of LDH and CK in the coronary 
artery effluent from the ischemia-reperfused heart, indicat- 
ing that Fe2+/H202 and xanthine/xanthine oxidase in- 
creased the ischemia-reperfusion injury of the my- 
ocardium. Addition of Chinonin into the reperfusion buffer 
Table 1 
Spectroscopic parameters of ischemia-reperfused myocardium and the activities of LDH and CK in the effluent from the ischemia-reperfused heart 
ESR signal at ESR signal at LDH (U /ml )  CK (U /ml )  
g = 2.04 (relative g = 2.03 (relative 
signal high) signal high) 
N(n=5)  0 0 4.0___ 1.1 2.7_+ 1.2 
N + LAI  (n = 5) 0 0 4.2 _+ 1.2 2.5 _+ 1.0 
N+ LA I0(n  = 5) 0 0 4.0_+ 1.0 2.6_+ 1.2 
N + LA100 (n = 5) 0 0 3.9 _+ 1.4 2.7 + 1.2 
IR (n = 10) 12.2 -+ 3.2 * 14.5 -+ 3.5 * 34.7 _+ 7.3 * 32.0 -+ 5.9 * 
IR + CN (n = 10) 7.2 _+ 2.6 *# 8.6 + 1.6 ~# 13.8 _+ 4.5 * # 18.4 _+ 3.2 ~# 
IR + NAME (n = 10) 6.5 _+ 1.1 *# 7.9_+ 1.5 *# 10.8 + 4.7 *# 12.4 ± 2.6 *# 
IR + LA I0  (n = 10) 13.5 _+ 3.6 * 16.1 _+ 2.1 * 36.3 _+ 8.3 ~ 34.5 _ 8.4 '~ 
IR + LA100 (n = 10) 15.7 + 2.5 * 18.5 -+ 2.0 * 46.7 _+ 7.8 ~ 42.6 _ 6.7 * 
IR+LAI0+CN(n= 10) 7 .3± 1.7 *@ 12.1_+ 1.6 *@ 17.0_+4.5 *@ 20 .0±5.8  *@ 
IR + SOD/CAT(n  = 10) 7.4 + 2.7 * @ 8.9-+ 1.8 * @ 17.5 _+ 2.1 * @ 12.0 ± 0.8 * @ 
IR + X /XO (n = 5) 20.2 + 4.3 * @ 16.0 _+ 2.8 * 85.0 _+ 5.6 * @ 71.0 _ 12.6 ~ @ 
IR + Fe2+/H~O2 (n = 5) 20.5 + 3.5 * @ 16.5 ± 9.1 * 113.0_+ 18.3 * @ 85.5 ± 10.5 ~ @ 
IR + Fe 2+ (n = 5) 14.0 _+ 1.7 ~ 16.2 _+ 2.3 * 50.5 _+ 3.5 " 45.5 _+ 5.5 ~ # 
IR + H202 (n = 5) 16.5 _+ 1.8 * # 16.6 _+ 2.5 * 47.5 _+ 4.5 * # 41.5 __+ 6.5 * 
N, normal; IR, ischemia-reperfusion; LA I ,  1 mmol /1  L-arginine; LA10, 10 mmol / l  L-arginine; LA I00,  100 mmol / I  L-arginine; CN, 100 /.tmol/1 
Chinonin; NAME,  100 mml / l  N~-nitro-L-arginine methyl ester; X, xanthine; XO, xanthine oxidase; CAT, catalase. The errors are the standard deviation. 
P < 0.05 versus N; # P > 0.05 versus IR; @ P < 0.05 versus IR + LA10. 
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Fig. 6. The ESR spectrum of Chinonin free radical obtained from reaction 
of 10 mmol/l Chinonin with 100 /~mol/1 Fe 2+/H202 then mixed with 
0.1 mmol NaOH (the ESR conditions were described in Section 2) (a) 
and their structures and reactions (b). 
decreased the activities of LDH and CK in the coronary 
artery effluent from the ischemia-reperfused heart. Similar 
to NAME and SOD/catalase, Chinonin can also protect 
the heart from the ischemia-reperfusion njury. 
In order to know how Chinonin scavenge the free 
radicals, the reaction of Chinonin with the hydroxyl free 
radicals generated by the Fenton reaction was studied and 
a Chinonin free radical was observed at alkaline solution 
(ESR spectrum in Fig. 6A, a~ = 0.25G, a 2 = 0.12G, a 3 = 
0.05G). The structures and the reaction are shown in Fig. 
6B. 
4. Discussion 
Chinonin is an effective component isolated from Chi- 
nese herb Rhizoma Anemarhenea which has been used for 
curing fever, cough, emission, lumbago, dizziness, dia- 
betes, pneumonia nd tracheitis. Recently it has been used 
on trial to cure heart disease. Here, the mechanism of 
curing these diseases, especially heart disease, was studied 
in the light of free radical theory. After scavenging the free 
radicals, Chinonin itself changed to free radicals, then 
decayed to non-free radical products in neutron pH and 
biological system, so they could not be detected. At alka- 
line condition, the free radicals are stable, so we could 
detect them (Fig. 6A). Chinonin is a kind of polyphenol 
compound which contains four hydroxyl groups in its 
structure (Fig. 6B). One Chinonin should scavenge 2-4 
free radicals in theory, but that needs to be proven by 
experiments. The two hydroxyls in the o position are more 
reactive than those in the m position, so they first react 
with free radical and form a semiquinone free radical (Fig. 
6B). 
More and more evidence indicates that oxygen free 
radicals play an important role in the generation and 
development of the diseases mentioned above and anti- 
oxidants have beneficial effects in preventing and curing 
heart diseases. So, for the first time, the scavenging effect 
of Chinonin on oxygen free radicals was studied and it was 
found that Chinonin could effectively scavenge the oxygen 
free radicals generated from the system of 
xanthine/xanthine oxidase. 
Recently it was proposed that NO reacts with O 2 in 
many pathological cases to yield cytotoxic ONOO- [20]. 
In alkaline solution, it is stable but has a pK a of 6.6 at 0°C 
and decays rapidly once protonated, to give the species 
such things as hydroxyl radical-like and NO 2, which can 
oxidize sulfhydryls and membrane lipids [21,22] and cause 
cell toxicity and some diseases. So, the inhibitory effect of 
Chinonin on the oxidative activity of ONOO- was studied 
and it was found that Chinonin could effectively inhibit the 
oxidative activity of ONOO-. Chinonin can simultane- 
ously scavenge oxygen free radicals and inhibit the oxida- 
tive activity of ONOO-, suggesting that the curing effect 
of Chinonin for the diseases mentioned above may be 
through this mechanism. 
The ESR method of measuring the NO bound to Hb at 
low temperature is a specific and sensitive technique which 
can give the information about NO bound to c~- or fl-sub- 
unit of Hb in T or R state. The peaks at g = 2.078 and 
g= 2.01 with splitting of 17.5G predominantly corre- 
sponds to a-NO complex[24,25]. In this work, a totally 
different signal was obtained, which has a peak at g = 2.04 
and valley at g = 2.015. This is the character of NO bound 
to the fl-subunit of Hb (fl-NO complex). Addition of 
Chinonin to the reperfusion solution decreased the signal 
at g = 2.04, suggesting that Chinonin can inhibit genera- 
tion of NO free radicals during the ischemia-reperfusion 
process. 
From the data in Table 1, it can be seen that a higher 
concentration of L-arginine causes more NO free radical 
generation and more serous injury in the ischemia-reper- 
fused myocardium. Addition of NAME to the reperfusion 
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solution inhibits the generation of NO and decreases the 
injury in the ischemia-reperfused myocardium. These re- 
sults suggest that the generation of NO free radicals during 
the ischemia-reperfusion is connected with the ischemia- 
reperfused injury. Addition of Chinonin to the reperfusion 
solution decreases the ischemia-reperfusion njury. 
SOD and catalase can protect he myocardium from the 
ischemia-reperfusion injury [26,27]. The results in this 
work also prove that conclusion. Addition of X /XO or 
Fe2+/Hz02 in the reperfusion solution caused the in- 
crease of LDH and CK activity in the effluent from the 
ischemia-reperfused h arts and aggravated the ischemia-re- 
perfused injury and at the same time increased the signals 
at g -- 2.04 and g = 2.03. Addition of Fe 2+ or H202 alone 
also caused the increase of LDH and CK activities in the 
effluent from the ischemia-reperfused heart and increase 
the signals at g = 2.04 and 2.03 but not as much as that of 
addition of Fe" /H202, especially the signal at g = 2.04. 
Addition of SOD/catalase in the reperfusion solution de- 
creased the activities of LDH and CK in the effluent from 
the ischemia-reperfused hearts and alleviated the 
ischemia-reperfusion njury and at the same time decreased 
the signals at g = 2.04 and g = 2.03. These results suggest 
that NO and oxygen free radicals have synergic effect in 
the ischemia-reperfusion injury of myocardium. Superox- 
ide anions can react with NO free radicals and form 
peroxynitrite which is a potent oxidant. Peroxynitrite may 
decompose to form hydroxyl-like and NO 2 free radicals 
when it is protonated, which can cause damage to the 
cellular components [21-23]. These may be the reason 
why when higher concentrations of L-arginine, X /XO and 
Fe2+/H202 were added into the reperfusion solution, the 
ischemia-reperfusion njury was aggravated and the gener- 
ation of NO and oxygen free radicals were increased 
simultaneously. Also the addition of SOD/catalase and 
NAME protected the myocardium against he ischemia-re- 
perfusion injury and decreased the generation of NO and 
oxygen free radicals simultaneously. Chinonin can scav- 
enge both NO and superoxide anions, so it can protect he 
myocardium from the ischemia-reperfusion njury and de- 
crease the generation of NO and oxygen free radicals in 
ischemia-reperfused myocardium, indicating that Chinonin 
is a potential medicine for curing heart disease. 
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